SCHEMBL6474400

SCHEMBL6474400

CCCN1c2ccc(C)cc2C(C)(C(=O)OCC)C12C=Nc1c(ccc3ccccc13)O2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.48
MAPT P10636 4/20 0.48
THRB P10828 4/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
ALOX12 P18054 2/20 0.48
PKM P14618 1/20 0.48
ALDH1A1 P00352 3/20 0.42
HPGD P15428 2/20 0.42
HTT P42858 2/20 0.42
LMNA P02545 2/20 0.42
MAPK1 P28482 2/20 0.42
GAA P10253 2/20 0.42
POLB P06746 1/20 0.42
RECQL P46063 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
ATM Q13315 2/20 0.36
CNR2 P34972 3/20 0.33
OPRM1 P35372 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6474870 0.93 KDM4E (0.47) KDM4EMAPTTHRBSMN1; SMN2L3MBTL1
SCHEMBL6482042 0.90 KDM4E (0.44) KDM4EMAPTTHRBSMN1; SMN2L3MBTL1
SCHEMBL6475808 0.84 KDM4E (0.55) KDM4EMAPTTHRBSMN1; SMN2L3MBTL1
SCHEMBL6473718 0.83 MAPT (0.52) KDM4EMAPTTHRBSMN1; SMN2L3MBTL1
SCHEMBL6482640 0.83 MAPT (0.66) KDM4EMAPTTHRBSMN1; SMN2L3MBTL1
SCHEMBL6473854 0.82 KDM4E (0.43) KDM4EMAPTTHRBSMN1; SMN2L3MBTL1
SCHEMBL6473829 0.81 KDM4E (0.52) KDM4EMAPTTHRBSMN1; SMN2L3MBTL1
SCHEMBL14552869 0.80 MAPT (0.58) KDM4EMAPTTHRBSMN1; SMN2L3MBTL1
SCHEMBL14552826 0.79 MAPT (0.49) KDM4EMAPTTHRBSMN1; SMN2L3MBTL1
SCHEMBL14552797 0.79 MAPT (0.49) KDM4EMAPTTHRBSMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6891038-B2 Photochromic spiro(indoline)naphthoxazines YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2005-05-10 US disclosed
US-20030114669-A1 Photochromic spiro(indoline)naphthoxazines YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) 2003-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030114669-A1 Photochromic spiro(indoline)naphthoxazines NPM1, CRY2, INMT KDM4E 1572/4885MAPT 2742/4885THRB 3454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.